Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

7 Results
Document type : Journal articles
Document type : Conference papers
Document type : Conference poster
Document type : Books
Document type : Book sections
Document type : Directions of work or proceedings
Document type : Patents
Document type : Other publications
labStructName_t : Department of Nuclear Medicine

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.

Pierre-Yves Salaun , Caroline Bodet-Milin , Eric Frampas , Aurore Oudoux , Catherine Saï-Maurel , et al.
Cancer, 2010, 116 (4 Suppl), pp.1053-8. ⟨10.1002/cncr.24792⟩
Journal articles hal-00930166v1

Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.

Françoise Kraeber-Bodéré , Pierre-Yves Salaun , Aurore Oudoux , David M Goldenberg , Jean-François Chatal , et al.
Cancer, 2010, 116 (4 Suppl), pp.1118-25. ⟨10.1002/cncr.24800⟩
Journal articles hal-00930004v1

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

Pierre-Yves Le Roux , Thomas Gastinne , Steven Le Gouill , Emmanuel Nowak , Caroline Bodet-Milin , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 (6), pp.1064-71. ⟨10.1007/s00259-011-1741-0⟩
Journal articles istex hal-00749883v1

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.

Pierre-Yves Salaun , Loïc Campion , Claire Bournaud , Alain Faivre-Chauvet , Jean-Philippe Vuillez , et al.
Journal of Nuclear Medicine, 2012, 53 (8), pp.1185-92. ⟨10.2967/jnumed.111.101865⟩
Journal articles hal-00932253v1

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.

Caroline Bodet-Milin , Ludovic Ferrer , Aurore Rauscher , Damien Masson , Latifa Rbah-Vidal , et al.
Frontiers in Medicine, 2014, 2, pp.84. ⟨10.3389/fmed.2015.00084⟩
Journal articles hal-01258870v1

Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).

Françoise Kraeber-Bodéré , Pierre-Yves Salaun , Catherine Ansquer , Delphine Drui , Eric Mirallié , et al.
Tumor Biology, 2012, 33 (3), pp.601-6. ⟨10.1007/s13277-012-0359-6⟩
Journal articles hal-00932128v1

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Ronan Abgral , Solène Querellou , Gaël Potard , Pierre-Yves Le Roux , Alexandra Le Duc-Pennec , et al.
Journal of Nuclear Medicine, 2009, 50 (1), pp.24-9. ⟨10.2967/jnumed.108.055806⟩
Journal articles hal-00922914v1